STJ St. Jude Medical Inc.
IndustryBiotechnology: Electromedical & Electrotherapeutic Apparatus
- 23.69 P/E
- 3.11 P/S
- 3.93 P/B
- 2.449 EPS
- 14.14% Cash ROIC
- 0.93 Cash Ratio
- 0.98 / 1.69 % Dividend
- 1.95M Avg. Vol.
- 327.09M Shares
- 16.846B Market Cap.
St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. It operates in four segments: Cardiac Rhythm Management, Cardiovascular, Atrial Fibrillation, and Neuromodulation. The Cardiac Rhythm Management segment offers products for cardiac arrhythmias, or irregular heart beats. Its products include tachycardia implantab...
4-traders (press release) - Dec 12, 2013
St. Jude Medical Gains CE Mark for 25 mm Portico Transcatheter Aortic Heart ... - Business Wire (press release)
WKRB News - Dec 9, 2013
4-traders (press release) - Dec 9, 2013
WKRB News - Dec 11, 2013
Insider Selling: Daniel Starks Unloads 108000 Shares of St. Jude Medical Stock ... - Zolmax
MarketWatch - Nov 21, 2013
MarketWatch - Dec 9, 2013
St. Jude Medical Inc. (STJ) Issues Q4 Earnings Guidance - Zolmax
Zacks.com - Dec 3, 2013
Seeking Alpha - Dec 3, 2013
Business Wire (press release) - Dec 4, 2013
St. Jude Medical Launches US Study of New Prodigy Neurostimulator to ... - MarketWatch
Ticker Report - Dec 10, 2013